Multiple nanotechnological approaches using natural compounds for diabetes management
Objectives Diabetes mellitus (DM) is a long-standing and non-transmissible endocrine disease that generates significant clinical issues and currently affects approximately 400 million people worldwide. The aim of the present review was to analyze the most relevant and recent studies that focused on...
Saved in:
| Published in | Journal of diabetes and metabolic disorders Vol. 23; no. 1; pp. 267 - 287 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Cham
Springer International Publishing
01.06.2024
BioMed Central Ltd Nature Publishing Group |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2251-6581 2251-6581 |
| DOI | 10.1007/s40200-023-01376-1 |
Cover
| Abstract | Objectives
Diabetes mellitus (DM) is a long-standing and non-transmissible endocrine disease that generates significant clinical issues and currently affects approximately 400 million people worldwide. The aim of the present review was to analyze the most relevant and recent studies that focused on the potential application of plant extracts and phytocompounds in nanotechnology for the treatment of T2DM.
Methods
Various databases were examined, including Springer Link, Google Scholar, PubMed, Wiley Online Library, and Science Direct. The search focused on discovering the potential application of nanoparticulate technologies in enhancing drug delivery of phytocompounds for the mentioned condition.
Results
Several drug delivery systems have been considered, that aimed to reduce adverse effects, while enhancing the efficiency of oral antidiabetic medications. Plant-based nanoformulations have been highlighted as an innovative approach for DM treatment due to their eco-friendly and cost-effective synthesis methods. Their benefits include targeted action, enhanced availability, stability, and reduced dosage frequency.
Conclusions
Nanomedicine has opened new opportunities for the diagnosis, treatment, and prevention of DM. The use of nanomaterials has demonstrated improved outcomes for both T1DM and T2DM. Notably, flavonoids, including substances such as quercetin, naringenin and myricitrin, have been recognized for their enhanced efficacy when delivered through novel nanotechnologies in preventing T2DM onset and associated complications. The perspectives on the addressed subject point to the development of more nanostructured phytocompounds with improved bioavailability and therapeutic efficacy. |
|---|---|
| AbstractList | ObjectivesDiabetes mellitus (DM) is a long-standing and non-transmissible endocrine disease that generates significant clinical issues and currently affects approximately 400 million people worldwide. The aim of the present review was to analyze the most relevant and recent studies that focused on the potential application of plant extracts and phytocompounds in nanotechnology for the treatment of T2DM.MethodsVarious databases were examined, including Springer Link, Google Scholar, PubMed, Wiley Online Library, and Science Direct. The search focused on discovering the potential application of nanoparticulate technologies in enhancing drug delivery of phytocompounds for the mentioned condition.ResultsSeveral drug delivery systems have been considered, that aimed to reduce adverse effects, while enhancing the efficiency of oral antidiabetic medications. Plant-based nanoformulations have been highlighted as an innovative approach for DM treatment due to their eco-friendly and cost-effective synthesis methods. Their benefits include targeted action, enhanced availability, stability, and reduced dosage frequency.ConclusionsNanomedicine has opened new opportunities for the diagnosis, treatment, and prevention of DM. The use of nanomaterials has demonstrated improved outcomes for both T1DM and T2DM. Notably, flavonoids, including substances such as quercetin, naringenin and myricitrin, have been recognized for their enhanced efficacy when delivered through novel nanotechnologies in preventing T2DM onset and associated complications. The perspectives on the addressed subject point to the development of more nanostructured phytocompounds with improved bioavailability and therapeutic efficacy. Diabetes mellitus (DM) is a long-standing and non-transmissible endocrine disease that generates significant clinical issues and currently affects approximately 400 million people worldwide. The aim of the present review was to analyze the most relevant and recent studies that focused on the potential application of plant extracts and phytocompounds in nanotechnology for the treatment of T2DM. Various databases were examined, including Springer Link, Google Scholar, PubMed, Wiley Online Library, and Science Direct. The search focused on discovering the potential application of nanoparticulate technologies in enhancing drug delivery of phytocompounds for the mentioned condition. Several drug delivery systems have been considered, that aimed to reduce adverse effects, while enhancing the efficiency of oral antidiabetic medications. Plant-based nanoformulations have been highlighted as an innovative approach for DM treatment due to their eco-friendly and cost-effective synthesis methods. Their benefits include targeted action, enhanced availability, stability, and reduced dosage frequency. Nanomedicine has opened new opportunities for the diagnosis, treatment, and prevention of DM. The use of nanomaterials has demonstrated improved outcomes for both T1DM and T2DM. Notably, flavonoids, including substances such as quercetin, naringenin and myricitrin, have been recognized for their enhanced efficacy when delivered through novel nanotechnologies in preventing T2DM onset and associated complications. The perspectives on the addressed subject point to the development of more nanostructured phytocompounds with improved bioavailability and therapeutic efficacy. Diabetes mellitus (DM) is a long-standing and non-transmissible endocrine disease that generates significant clinical issues and currently affects approximately 400 million people worldwide. The aim of the present review was to analyze the most relevant and recent studies that focused on the potential application of plant extracts and phytocompounds in nanotechnology for the treatment of T2DM.ObjectivesDiabetes mellitus (DM) is a long-standing and non-transmissible endocrine disease that generates significant clinical issues and currently affects approximately 400 million people worldwide. The aim of the present review was to analyze the most relevant and recent studies that focused on the potential application of plant extracts and phytocompounds in nanotechnology for the treatment of T2DM.Various databases were examined, including Springer Link, Google Scholar, PubMed, Wiley Online Library, and Science Direct. The search focused on discovering the potential application of nanoparticulate technologies in enhancing drug delivery of phytocompounds for the mentioned condition.MethodsVarious databases were examined, including Springer Link, Google Scholar, PubMed, Wiley Online Library, and Science Direct. The search focused on discovering the potential application of nanoparticulate technologies in enhancing drug delivery of phytocompounds for the mentioned condition.Several drug delivery systems have been considered, that aimed to reduce adverse effects, while enhancing the efficiency of oral antidiabetic medications. Plant-based nanoformulations have been highlighted as an innovative approach for DM treatment due to their eco-friendly and cost-effective synthesis methods. Their benefits include targeted action, enhanced availability, stability, and reduced dosage frequency.ResultsSeveral drug delivery systems have been considered, that aimed to reduce adverse effects, while enhancing the efficiency of oral antidiabetic medications. Plant-based nanoformulations have been highlighted as an innovative approach for DM treatment due to their eco-friendly and cost-effective synthesis methods. Their benefits include targeted action, enhanced availability, stability, and reduced dosage frequency.Nanomedicine has opened new opportunities for the diagnosis, treatment, and prevention of DM. The use of nanomaterials has demonstrated improved outcomes for both T1DM and T2DM. Notably, flavonoids, including substances such as quercetin, naringenin and myricitrin, have been recognized for their enhanced efficacy when delivered through novel nanotechnologies in preventing T2DM onset and associated complications. The perspectives on the addressed subject point to the development of more nanostructured phytocompounds with improved bioavailability and therapeutic efficacy.ConclusionsNanomedicine has opened new opportunities for the diagnosis, treatment, and prevention of DM. The use of nanomaterials has demonstrated improved outcomes for both T1DM and T2DM. Notably, flavonoids, including substances such as quercetin, naringenin and myricitrin, have been recognized for their enhanced efficacy when delivered through novel nanotechnologies in preventing T2DM onset and associated complications. The perspectives on the addressed subject point to the development of more nanostructured phytocompounds with improved bioavailability and therapeutic efficacy. Diabetes mellitus (DM) is a long-standing and non-transmissible endocrine disease that generates significant clinical issues and currently affects approximately 400 million people worldwide. The aim of the present review was to analyze the most relevant and recent studies that focused on the potential application of plant extracts and phytocompounds in nanotechnology for the treatment of T2DM. Various databases were examined, including Springer Link, Google Scholar, PubMed, Wiley Online Library, and Science Direct. The search focused on discovering the potential application of nanoparticulate technologies in enhancing drug delivery of phytocompounds for the mentioned condition. Several drug delivery systems have been considered, that aimed to reduce adverse effects, while enhancing the efficiency of oral antidiabetic medications. Plant-based nanoformulations have been highlighted as an innovative approach for DM treatment due to their eco-friendly and cost-effective synthesis methods. Their benefits include targeted action, enhanced availability, stability, and reduced dosage frequency. Nanomedicine has opened new opportunities for the diagnosis, treatment, and prevention of DM. The use of nanomaterials has demonstrated improved outcomes for both T1DM and T2DM. Notably, flavonoids, including substances such as quercetin, naringenin and myricitrin, have been recognized for their enhanced efficacy when delivered through novel nanotechnologies in preventing T2DM onset and associated complications. The perspectives on the addressed subject point to the development of more nanostructured phytocompounds with improved bioavailability and therapeutic efficacy. Objectives Diabetes mellitus (DM) is a long-standing and non-transmissible endocrine disease that generates significant clinical issues and currently affects approximately 400 million people worldwide. The aim of the present review was to analyze the most relevant and recent studies that focused on the potential application of plant extracts and phytocompounds in nanotechnology for the treatment of T2DM. Methods Various databases were examined, including Springer Link, Google Scholar, PubMed, Wiley Online Library, and Science Direct. The search focused on discovering the potential application of nanoparticulate technologies in enhancing drug delivery of phytocompounds for the mentioned condition. Results Several drug delivery systems have been considered, that aimed to reduce adverse effects, while enhancing the efficiency of oral antidiabetic medications. Plant-based nanoformulations have been highlighted as an innovative approach for DM treatment due to their eco-friendly and cost-effective synthesis methods. Their benefits include targeted action, enhanced availability, stability, and reduced dosage frequency. Conclusions Nanomedicine has opened new opportunities for the diagnosis, treatment, and prevention of DM. The use of nanomaterials has demonstrated improved outcomes for both T1DM and T2DM. Notably, flavonoids, including substances such as quercetin, naringenin and myricitrin, have been recognized for their enhanced efficacy when delivered through novel nanotechnologies in preventing T2DM onset and associated complications. The perspectives on the addressed subject point to the development of more nanostructured phytocompounds with improved bioavailability and therapeutic efficacy. Objectives Diabetes mellitus (DM) is a long-standing and non-transmissible endocrine disease that generates significant clinical issues and currently affects approximately 400 million people worldwide. The aim of the present review was to analyze the most relevant and recent studies that focused on the potential application of plant extracts and phytocompounds in nanotechnology for the treatment of T2DM. Methods Various databases were examined, including Springer Link, Google Scholar, PubMed, Wiley Online Library, and Science Direct. The search focused on discovering the potential application of nanoparticulate technologies in enhancing drug delivery of phytocompounds for the mentioned condition. Results Several drug delivery systems have been considered, that aimed to reduce adverse effects, while enhancing the efficiency of oral antidiabetic medications. Plant-based nanoformulations have been highlighted as an innovative approach for DM treatment due to their eco-friendly and cost-effective synthesis methods. Their benefits include targeted action, enhanced availability, stability, and reduced dosage frequency. Conclusions Nanomedicine has opened new opportunities for the diagnosis, treatment, and prevention of DM. The use of nanomaterials has demonstrated improved outcomes for both T1DM and T2DM. Notably, flavonoids, including substances such as quercetin, naringenin and myricitrin, have been recognized for their enhanced efficacy when delivered through novel nanotechnologies in preventing T2DM onset and associated complications. The perspectives on the addressed subject point to the development of more nanostructured phytocompounds with improved bioavailability and therapeutic efficacy. Keywords: diabetes mellitus, Plant extracts, Phytocompounds, Nanoformulations |
| Audience | General |
| Author | Macovei, Irina Mircea, Cornelia Stoleru, Ozana Andreea Burlec, Ana Flavia Felea, Maura Gabriela Corciovă, Andreia Hăncianu, Monica |
| Author_xml | – sequence: 1 givenname: Ozana Andreea surname: Stoleru fullname: Stoleru, Ozana Andreea organization: Faculty of Pharmacy, “Grigore T. Popa” University of Medicine and Pharmacy – sequence: 2 givenname: Ana Flavia surname: Burlec fullname: Burlec, Ana Flavia email: ana-flavia.l.burlec@umfiasi.ro organization: Faculty of Pharmacy, “Grigore T. Popa” University of Medicine and Pharmacy – sequence: 3 givenname: Cornelia surname: Mircea fullname: Mircea, Cornelia email: corneliamircea@yahoo.com organization: Faculty of Pharmacy, “Grigore T. Popa” University of Medicine and Pharmacy – sequence: 4 givenname: Maura Gabriela surname: Felea fullname: Felea, Maura Gabriela organization: Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy – sequence: 5 givenname: Irina surname: Macovei fullname: Macovei, Irina organization: Faculty of Pharmacy, “Grigore T. Popa” University of Medicine and Pharmacy – sequence: 6 givenname: Monica surname: Hăncianu fullname: Hăncianu, Monica organization: Faculty of Pharmacy, “Grigore T. Popa” University of Medicine and Pharmacy – sequence: 7 givenname: Andreia surname: Corciovă fullname: Corciovă, Andreia organization: Faculty of Pharmacy, “Grigore T. Popa” University of Medicine and Pharmacy |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38932892$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kt1v1SAYxhsz4-bcP-CFaWJivOnkowV6ZZZlfiQz3rhrwqFvWxYKtVAT_3vfs7PpOYsZXEDg9zzAw_uyOAoxQFG8puScEiI_pJowQirCeEUol6Kiz4oTxhpaiUbRo735cXGW0i3BJqVSVLwojrlqOVMtOyluvq0-u9lDGUyIGewYoo-Ds8aXZp6XaOwIqVyTCwMieV1ww8ZpjmvoUtnHpeyc2UBGaDLBDDBByK-K573xCc7ux9Pi5tPVj8sv1fX3z18vL64r20ieq74DuWn72gpGpKmJpURATXHsZd0r1YFqeE2oJS2zGwJGcNnSlvStbFrglp8WH3e-87qZoLN4NN5Pz4ubzPJbR-P04U5wox7iL00pbQUGhA7v7x2W-HOFlPXkkgXvTYC4Js2JZIo2hAlE3z5Cb-O6BHyf5lRwxUTN96jBeNAu9BEPtltTfYH5M8rqhiN1_h8KeweTs_jTvcP1A8G7PcEIxucxRb9mF0M6BN_sR_I3i4cvR0DtALvElBbotXXZbH3wCs5rSvS2wPSuwDQWmL4rML0Niz2SPrg_KeI7UUI4DLD8i-0J1R9V2eCP |
| CitedBy_id | crossref_primary_10_1007_s10068_024_01695_w crossref_primary_10_2147_IJN_S487188 |
| Cites_doi | 10.1016/j.jconrel.2021.01.002 10.3390/antiox12030732 10.2337/db13-0949 10.3390/plants11070893 10.1039/D0NR06104B 10.1039/C5RA24391B 10.1093/ajcn/79.5.727 10.1155/2018/7496936 10.1038/s41598-023-36929-0 10.1016/j.rechem.2022.100367 10.1186/s43042-022-00282-0 10.2337/cd22-0038 10.1007/s00125-017-4336-x 10.1016/j.arabjc.2020.02.009 10.1016/j.ijpharm.2021.121208 10.1016/j.ejps.2017.05.068 10.1080/10717544.2018.1469685 10.1016/S0140-6736(20)32374-6 10.4103/2230-8210.176351 10.1016/j.ijbiomac.2018.09.010 10.1016/j.mce.2013.06.014 10.3109/03639045.2015.1135934 10.3390/ijms21176275 10.1021/acsami.8b03868 10.1111/bph.13816 10.1016/j.biopha.2020.110941 10.3390/biomedicines10102436 10.1016/j.jddst.2023.104264 10.3389/fphar.2018.00892 10.1016/j.jphotobiol.2019.111541 10.1016/j.apt.2020.03.004 10.4239/wjd.v6.i3.456 10.1080/10408398.2019.1679085 10.2337/dci20-0022 10.1002/ptr.6904 10.1016/j.carbpol.2017.04.066 10.1016/j.nutres.2012.06.003 10.5114/aoms.2015.53304 10.1007/s13346-018-00609-8 10.1111/jphp.12672 10.1016/j.biopha.2017.11.026 10.1007/s11095-020-02883-z 10.1016/j.tifs.2017.07.008 10.1016/j.jksus.2022.102197 10.1007/978-3-319-27027-2_21 10.4161/oxim.2.5.9498 10.1208/s12249-016-0537-8 10.1016/j.nano.2017.11.012 10.3390/nano13030574 10.1016/j.jconrel.2019.01.029 10.1002/ptr.5529 10.1016/j.arabjc.2017.05.011 10.3390/nano8030174 10.1136/postgradmedj-2019-137404 10.5694/mja2.50472 10.1016/j.msec.2018.12.058 10.1016/j.ajps.2020.05.001 10.1016/bs.afnr.2019.02.006 10.1016/j.jinorgbio.2019.110782 10.1016/j.ijbiomac.2019.11.031 10.1016/j.bcab.2021.101983 10.1016/j.ijbiomac.2015.11.070 10.1211/0022357055416 10.3390/ph12010011 10.1016/j.ijbiomac.2018.01.063 10.2337/db12-1215 10.1016/j.jacc.2020.05.037 10.4137/BMI.S38440 10.1080/14686996.2020.1788907 10.1016/j.ijbiomac.2018.12.009 10.1088/1757-899X/805/1/012035 10.1016/j.lfs.2018.10.027 10.1016/j.ijbiomac.2022.03.004 10.1007/s13346-012-0063-5 10.18773/austprescr.2014.005 10.1007/s43450-022-00231-3 10.1016/j.ijpharm.2017.07.083 10.1016/j.ijpharm.2019.01.019 10.1089/jmf.2011.0243 10.13187/ejm.2014.6.226 10.3390/ijms231910988 10.1016/j.cej.2020.124630 10.2147/IJN.S146978 10.3390/polym14153217 10.2337/dc12-0116 10.1166/jnn.2018.15247 10.1016/j.eurpolymj.2020.109818 10.3390/medicines6030094 10.1177/2042018820980225 10.3390/pharmaceutics13020291 10.1016/j.cis.2020.102251 10.2337/dcS13-2011 10.1056/NEJMcp2000280 10.1016/j.jtcme.2015.03.005 10.1016/j.rechem.2022.100509 10.1038/ejcn.2016.142 10.1016/j.sjbs.2015.06.026 10.1016/j.molmet.2017.06.019 10.1016/j.fitote.2019.02.033 10.1016/j.ejphar.2009.05.015 10.3390/antiox11061085 10.1016/j.bioactmat.2021.04.040 10.1142/S1793292021501496 10.18773/austprescr.2004.059 10.3164/jcbn.40.163 10.1016/j.jtcme.2016.08.004 10.1007/s13346-022-01163-0 10.3389/fendo.2021.669448 10.1016/j.beem.2009.03.004 10.1111/dme.12231 10.1016/j.pnpbp.2011.06.002 10.1016/j.colsurfb.2019.02.024 10.1016/j.metabol.2022.155332 10.1016/j.jtcme.2017.08.012 10.1088/1757-899X/172/1/012042 |
| ContentType | Journal Article |
| Copyright | The Author(s), under exclusive licence to Tehran University of Medical Sciences 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. COPYRIGHT 2024 BioMed Central Ltd. Copyright BioMed Central 2024 |
| Copyright_xml | – notice: The Author(s), under exclusive licence to Tehran University of Medical Sciences 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: COPYRIGHT 2024 BioMed Central Ltd. – notice: Copyright BioMed Central 2024 |
| DBID | AAYXX CITATION NPM K9. 7X8 5PM |
| DOI | 10.1007/s40200-023-01376-1 |
| DatabaseName | CrossRef PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2251-6581 |
| EndPage | 287 |
| ExternalDocumentID | PMC11196251 A778212453 38932892 10_1007_s40200_023_01376_1 |
| Genre | Journal Article Review |
| GroupedDBID | -A0 -EM 0R~ 2NT 3V. 406 5VS 7X7 8FI 8FJ AACDK AAHNG AAJBT AASML AATNV AAUYE ABAKF ABDZT ABECU ABFTV ABJNI ABKCH ABMQK ABSXP ABTEG ABTKH ABTMW ABUWG ACAOD ACDTI ACGFS ACHSB ACOKC ACPIV ACZOJ ADBBV ADINQ ADKNI ADRAZ ADURQ ADYFF AEFQL AEMSY AESKC AFBBN AFKRA AFQWF AGDGC AGJBK AGMZJ AGQEE AGRTI AHBYD AHSBF AHYZX AIAKS AIGIU AILAN AITGF AJZVZ ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMXSW AMYLF AOIJS AXYYD BAWUL BENPR BFQNJ BPHCQ BVXVI C24 CCPQU CWDGH DIK DPUIP EBLON EBS EJD FIGPU FINBP FNLPD FSGXE FYUFA GGCAI GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR IHW IKXTQ IPNFZ ITC IWAJR J-C JZLTJ KQ8 LLZTM M48 M~E NPVJJ NQJWS O9J OK1 PQQKQ PROAC PT4 RBZ RIG ROL RPM RSV SJYHP SMD SNE SNPRN SOHCF SOJ SRMVM SSLCW STPWE UKHRP UOJIU UTJUX ZMTXR AAYXX ABBRH ABDBE ABFSG ACSTC AEZWR AFDZB AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION NPM AEIIB ABRTQ K9. 7X8 5PM |
| ID | FETCH-LOGICAL-c573t-fde7b9f4c6207a40c106e410c1f74f88de853401c092cb0ea6379190f9759e3c3 |
| IEDL.DBID | M48 |
| ISSN | 2251-6581 |
| IngestDate | Thu Aug 21 18:35:05 EDT 2025 Fri Sep 05 09:11:23 EDT 2025 Wed Sep 17 23:57:10 EDT 2025 Tue Jun 17 22:24:28 EDT 2025 Tue Jun 10 21:19:36 EDT 2025 Thu May 22 21:06:10 EDT 2025 Wed Feb 19 02:02:55 EST 2025 Tue Jul 01 01:29:49 EDT 2025 Thu Apr 24 22:58:16 EDT 2025 Fri Feb 21 02:42:05 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Phytocompounds diabetes mellitus Nanoformulations Plant extracts |
| Language | English |
| License | The Author(s), under exclusive licence to Tehran University of Medical Sciences 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c573t-fde7b9f4c6207a40c106e410c1f74f88de853401c092cb0ea6379190f9759e3c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/11196251 |
| PMID | 38932892 |
| PQID | 3163826436 |
| PQPubID | 105772 |
| PageCount | 21 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11196251 proquest_miscellaneous_3072815026 proquest_journals_3163826436 gale_infotracmisc_A778212453 gale_infotracacademiconefile_A778212453 gale_healthsolutions_A778212453 pubmed_primary_38932892 crossref_citationtrail_10_1007_s40200_023_01376_1 crossref_primary_10_1007_s40200_023_01376_1 springer_journals_10_1007_s40200_023_01376_1 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2024-06-01 |
| PublicationDateYYYYMMDD | 2024-06-01 |
| PublicationDate_xml | – month: 06 year: 2024 text: 2024-06-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Cham |
| PublicationPlace_xml | – name: Cham – name: Switzerland – name: London |
| PublicationTitle | Journal of diabetes and metabolic disorders |
| PublicationTitleAbbrev | J Diabetes Metab Disord |
| PublicationTitleAlternate | J Diabetes Metab Disord |
| PublicationYear | 2024 |
| Publisher | Springer International Publishing BioMed Central Ltd Nature Publishing Group |
| Publisher_xml | – name: Springer International Publishing – name: BioMed Central Ltd – name: Nature Publishing Group |
| References | Sharma, Nagraik, Sharma (CR65) 2022; 4 Bertsch (CR40) 2022; 40 Jafari, Sattari, Ghavamzadeh (CR28) 2017; 7 Manach, Scalbert, Morand (CR74) 2004; 79 Wang, Liu, Zhang (CR111) 2013; 376 Wang, Wang, Li (CR1) 2021; 330 Kalra, Baruah, Sahay (CR19) 2016; 20 Simos, Spyrou, Patila (CR14) 2021; 16 Kalyani (CR15) 2021; 384 Khan, Saeed, Khan (CR38) 2019; 12 Prasad, Lambe, Brar (CR37) 2018; 97 Da Silva, Ferreira, Pintado, Sarmento (CR99) 2016; 84 Gullón, Lú-Chau, Moreira, Lema, Eibes (CR105) 2017; 67 Chan, Lim, Wareham (CR3) 2020; 396 Tsoutsouki, Wunna, Chowdhury, Chowdhury (CR12) 2020; 96 Sola, Rossi, Schianca (CR17) 2015; 11 Shahwan, Alhumaydhi, Ashraf (CR75) 2022; 206 Knop, Konings, Timmers (CR29) 2013; 30 He, Song, Zou (CR34) 2016; 30 Qiu, Wang, Zhang, Wang (CR41) 2022; 14 Chauhan, Tamrakar, Mahajan, Prasad (CR93) 2018; 13 Escobar-Chaves, Acin, Muñoz (CR116) 2023; 81 Wang, Wang, Firempong, Zhang, Wang, Zhang, Zhu, Yu, Xu (CR83) 2017; 18 Ahangarpour, Oroojan, Khorsandi (CR87) 2018; 2018 Wainstein, Ganz, Boaz, Bar Dayan, Dolev, Kerem, Madar (CR32) 2012; 15 Konstantinidi, Koutelidakis (CR33) 2019; 6 Hu, Gao, Boakye-Yiadom (CR92) 2021; 6 Negahdari, Bohlouli, Sharifi (CR106) 2021; 35 Choudhury, Pandey, Hua (CR22) 2018; 8 Wang, Zheng, Shi, Zhao (CR55) 2019; 9 Malapermal, Botha, Krishna, Mbatha (CR57) 2017; 24 Maity, Mukhopadhyay, Kundu, Chakraborti (CR82) 2017; 170 Oladipo, Lateef, Azeez (CR69) 2020; 805 Nagula, Wairkar (CR86) 2019; 296 Lingling, Yuan, Weigen (CR115) 2016; 42 Maestrelli, Mura, González-Rodríguez (CR44) 2017; 530 Sherwani, Khan, Ekhzaimy (CR110) 2016; 11 Aloke, Egwu, Aja (CR2) 2022; 10 Chinnaiyan, Deivasigamani, Gadela (CR46) 2019; 125 Deepa, Mohan, Manimaran (CR61) 2022; 4 Zhang, Li, Wang (CR112) 2020; 390 Das, Everett, Birtcher (CR11) 2020; 76 Yang, Chen, Liu (CR53) 2021; 133 Mohammadi Arvanag, Bayrami, Habibi-Yangjeh, Rahim (CR66) 2019; 97 Thornberry, Gallwitz (CR20) 2009; 23 Vinotha, Iswarya, Thaya (CR63) 2019; 197 Pereira, Siba, Chioca (CR88) 2011; 35 Sharma, Katiyar, Agrawal (CR108) 2018; 2018 Chung, Erion, Florez (CR4) 2020; 43 Liu, Chen, Wang (CR50) 2018; 10 Pérez Gutiérrez, Soto Contreras, Martínez Jerónimo (CR62) 2022; 11 Su, Zhao, Xu, Weng (CR95) 2022; 11 DeMarsilis, Reddy, Boutari (CR10) 2022; 137 Rajasekaran, Sivagnanam, Subramanian (CR23) 2010; 57 Bayrami, Haghgooie, Rahim Pouran (CR64) 2020; 31 Alaa, Abdelaziz, Mustafa (CR49) 2023; 13 Bhatt, Thomas, Nanjan (CR30) 2012; 32 Kumar, Bhanjana, Verma (CR51) 2017; 69 Hussein, El-Naggar (CR76) 2021; 33 Salehi, Fokou, Sharifi-Rad (CR80) 2019; 12 Khan, Nabi, Rehman (CR47) 2021; 16 Thynne, Doogue (CR21) 2014; 37 Libianto, Davis, Ekinci (CR9) 2020; 212 Sanchez-Rangel, Inzucchi (CR13) 2017; 60 Zhang, Li, Xu, Yao (CR48) 2018; 25 Zhang, Xiong, Ali (CR45) 2021; 13 Dimas, Lagou, Barker (CR6) 2014; 63 He, Chen, Li (CR56) 2019; 134 Aljabali, Akkam, Zoubi, Al-Batayneh, Al-Trad, Abo Alrob, Alkilany, Benamara, Evans (CR70) 2018; 8 Tong, Liu, Yan (CR78) 2017; 12 Anderson, Zhan, Luo (CR25) 2016; 6 Martakov, Shevchenko, Torlopov (CR100) 2019; 199 Galicia-Garcia, Benito-Vicente, Jebari (CR5) 2020; 21 Pandey, Rizvi (CR73) 2009; 2 Nagoor Meeran, Goyal, Suchal (CR114) 2018; 9 Amjadi, Shahnaz, Shokouhi (CR107) 2021; 610 Ganugula, Arora, Jaisamut (CR89) 2017; 174 Greenfield, Chisholm (CR18) 2004; 27 Bacanli, Dilsiz, Başaran, Başaran (CR72) 2019; 89 Chuengsamarn, Rattanamongkolgul, Luechapudiporn, Phisalaphong, Jirawatnotai (CR27) 2012; 35 Yücel, Karatoprak, Aktaş (CR96) 2018; 18 Fan, Li, Li (CR60) 2020; 21 Abdel-Moneim, El-Shahawy, Yousef (CR97) 2020; 154 Zhang, Zhang, Ban (CR102) 2018; 14 Kaur, Valecha (CR36) 2014; 6 Haghani, Arabnezhad, Mohammadi, Ghaffarian-Bahraman (CR31) 2022; 32 Marton, Pescinini-e-Salzedas, Camargo (CR26) 2021; 12 Ayyoub, Al-Trad, Aljabali (CR68) 2022; 12 Tangvarasittichai (CR24) 2015; 6 Guo, Yang, Tan (CR103) 2016; 70 Elekofehinti (CR58) 2022; 23 Baker, Retzik-Stahr, Singh (CR16) 2021; 12 DeFronzo, Eldor, Abdul-Ghani (CR7) 2013; 36 Chitkara, Nikalaje, Mittal (CR79) 2012; 2 Modak, Dixit, Londhe (CR35) 2007; 40 Rani, Dahiya, Dhingra (CR52) 2017; 106 Najmanová, Vopršalová, Saso, Mladěnka (CR85) 2020; 60 Bhia, Motallebi, Abadi (CR81) 2021; 13 Balan, Qing, Wang (CR59) 2016; 6 Mandić, Matković, Baranović, Šegota (CR77) 2023; 12 Rehman, Jafari, Tong (CR42) 2020; 284 Masood, Ahmed, Tariq, Ahmed, Masoud, Ali, Asghar, Andleeb, Hasan (CR54) 2019; 559 Maity, Chakraborti (CR84) 2020; 134 Chauhan, Tamrakar, Mahajan, Prasad (CR90) 2018; 213 Kim, Lee, Kim (CR98) 2009; 615 Joseph, Kar Mahapatra, Esmaeili (CR39) 2023; 13 Castellano, Guinda, Delgado (CR113) 2013; 62 Acevedo-Guevara, Nieto-Suaza, Sanchez (CR43) 2018; 111 Colorado, Fernandez, Orozco, Lopera, Muñoz, Acín (CR104) 2020; 37 Tan, Tseng, Zhong (CR109) 2022; 23 Akbar, Zia, Akash (CR94) 2018; 120 El-Naggar, Al-Joufi, Anwar (CR91) 2019; 177 CR101 Guo, Jiang, Zhang, Yin (CR67) 2020; 13 Chen, Cohrs, Stertmann (CR8) 2017; 6 Sekar, Al-Ansari, Narenkumar (CR71) 2022; 34 J Liu (1376_CR50) 2018; 10 F Mohammadi Arvanag (1376_CR66) 2019; 97 SI Sherwani (1376_CR110) 2016; 11 S Chuengsamarn (1376_CR27) 2012; 35 R Rani (1376_CR52) 2017; 106 TM Joseph (1376_CR39) 2023; 13 H Alaa (1376_CR49) 2023; 13 Y Zhang (1376_CR112) 2020; 390 SK Chinnaiyan (1376_CR46) 2019; 125 YV Simos (1376_CR14) 2021; 16 J Wainstein (1376_CR32) 2012; 15 T Deepa (1376_CR61) 2022; 4 A DeMarsilis (1376_CR10) 2022; 137 Y Guo (1376_CR67) 2020; 13 D Fan (1376_CR60) 2020; 21 A Abdel-Moneim (1376_CR97) 2020; 154 U Galicia-Garcia (1376_CR5) 2020; 21 SR Das (1376_CR11) 2020; 76 R Ganugula (1376_CR89) 2017; 174 Y Wang (1376_CR1) 2021; 330 M Bhia (1376_CR81) 2021; 13 X Guo (1376_CR103) 2016; 70 M Konstantinidi (1376_CR33) 2019; 6 JM Castellano (1376_CR113) 2013; 62 P Chauhan (1376_CR90) 2018; 213 B Hu (1376_CR92) 2021; 6 C Aloke (1376_CR2) 2022; 10 D Tan (1376_CR109) 2022; 23 LT Marton (1376_CR26) 2021; 12 K He (1376_CR34) 2016; 30 A Aljabali (1376_CR70) 2018; 8 MU Akbar (1376_CR94) 2018; 120 X Wang (1376_CR111) 2013; 376 IS Martakov (1376_CR100) 2019; 199 T Bertsch (1376_CR40) 2022; 40 A Ahangarpour (1376_CR87) 2018; 2018 S Rajasekaran (1376_CR23) 2010; 57 D Sola (1376_CR17) 2015; 11 S Ayyoub (1376_CR68) 2022; 12 OO Elekofehinti (1376_CR58) 2022; 23 Z Zhang (1376_CR48) 2018; 25 JH Kim (1376_CR98) 2009; 615 D Colorado (1376_CR104) 2020; 37 V Sekar (1376_CR71) 2022; 34 M Pereira (1376_CR88) 2011; 35 Y Zhang (1376_CR45) 2021; 13 JR Greenfield (1376_CR18) 2004; 27 M Modak (1376_CR35) 2007; 40 R Libianto (1376_CR9) 2020; 212 A Sharma (1376_CR65) 2022; 4 1376_CR101 RM Pérez Gutiérrez (1376_CR62) 2022; 11 D Chitkara (1376_CR79) 2012; 2 RA DeFronzo (1376_CR7) 2013; 36 S Maity (1376_CR82) 2017; 170 P Chauhan (1376_CR93) 2018; 13 RR Kalyani (1376_CR15) 2021; 384 ME El-Naggar (1376_CR91) 2019; 177 S Amjadi (1376_CR107) 2021; 610 C Manach (1376_CR74) 2004; 79 C Baker (1376_CR16) 2021; 12 KB Pandey (1376_CR73) 2009; 2 K Balan (1376_CR59) 2016; 6 N Masood (1376_CR54) 2019; 559 AS Dimas (1376_CR6) 2014; 63 F Tong (1376_CR78) 2017; 12 T Khan (1376_CR47) 2021; 16 J Hussein (1376_CR76) 2021; 33 I Najmanová (1376_CR85) 2020; 60 B Gullón (1376_CR105) 2017; 67 Y Yang (1376_CR53) 2021; 133 F Maestrelli (1376_CR44) 2017; 530 Y Wang (1376_CR83) 2017; 18 JCN Chan (1376_CR3) 2020; 396 M Prasad (1376_CR37) 2018; 97 A Rehman (1376_CR42) 2020; 284 V Vinotha (1376_CR63) 2019; 197 V Malapermal (1376_CR57) 2017; 24 Y Zhang (1376_CR102) 2018; 14 E Sanchez-Rangel (1376_CR13) 2017; 60 F Haghani (1376_CR31) 2022; 32 S Kumar (1376_CR51) 2017; 69 M Bacanli (1376_CR72) 2019; 89 MF Nagoor Meeran (1376_CR114) 2018; 9 S Tangvarasittichai (1376_CR24) 2015; 6 E Escobar-Chaves (1376_CR116) 2023; 81 I Khan (1376_CR38) 2019; 12 A Qiu (1376_CR41) 2022; 14 IC Oladipo (1376_CR69) 2020; 805 Ç Yücel (1376_CR96) 2018; 18 SB Da Silva (1376_CR99) 2016; 84 H Choudhury (1376_CR22) 2018; 8 T Thynne (1376_CR21) 2014; 37 A Bayrami (1376_CR64) 2020; 31 J Tsoutsouki (1376_CR12) 2020; 96 JK Bhatt (1376_CR30) 2012; 32 FK Knop (1376_CR29) 2013; 30 B Salehi (1376_CR80) 2019; 12 C Chen (1376_CR8) 2017; 6 RL Nagula (1376_CR86) 2019; 296 NA Thornberry (1376_CR20) 2009; 23 S Jafari (1376_CR28) 2017; 7 S Kalra (1376_CR19) 2016; 20 WK Chung (1376_CR4) 2020; 43 R Negahdari (1376_CR106) 2021; 35 L Acevedo-Guevara (1376_CR43) 2018; 111 M Kaur (1376_CR36) 2014; 6 J-H He (1376_CR56) 2019; 134 M Su (1376_CR95) 2022; 11 G Lingling (1376_CR115) 2016; 42 M Shahwan (1376_CR75) 2022; 206 L Mandić (1376_CR77) 2023; 12 V Sharma (1376_CR108) 2018; 2018 RA Anderson (1376_CR25) 2016; 6 T Wang (1376_CR55) 2019; 9 S Maity (1376_CR84) 2020; 134 |
| References_xml | – volume: 330 start-page: 618 year: 2021 end-page: 640 ident: CR1 article-title: Recent advances of nanomedicine-based strategies in diabetes and complications management: Diagnostics, monitoring, and therapeutics publication-title: J Control Release doi: 10.1016/j.jconrel.2021.01.002 – volume: 12 start-page: 732 year: 2023 ident: CR77 article-title: The increased release kinetics of quercetin from superparamagnetic nanocarriers in dialysis publication-title: Antioxidants doi: 10.3390/antiox12030732 – volume: 63 start-page: 2158 year: 2014 end-page: 2171 ident: CR6 article-title: Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity publication-title: Diabetes doi: 10.2337/db13-0949 – volume: 11 start-page: 893 year: 2022 ident: CR62 article-title: Assessing the ameliorative effect of selenium , , and nanoparticles in diabetic zebrafish ( ) publication-title: Plants doi: 10.3390/plants11070893 – volume: 13 start-page: 776 year: 2021 end-page: 789 ident: CR45 article-title: Layer-by-layer coated nanoliposomes for oral delivery of insulin publication-title: Nanoscale doi: 10.1039/D0NR06104B – volume: 6 start-page: 40162 year: 2016 end-page: 40168 ident: CR59 article-title: Antidiabetic activity of silver nanoparticles from green synthesis using leaf extract publication-title: RSC Adv doi: 10.1039/C5RA24391B – volume: 79 start-page: 727 year: 2004 end-page: 747 ident: CR74 article-title: Polyphenols: food sources and bioavailability publication-title: Am J Clin Nutr doi: 10.1093/ajcn/79.5.727 – volume: 2018 start-page: 1 year: 2018 end-page: 18 ident: CR87 article-title: Solid lipid nanoparticles of myricitrin have antioxidant and antidiabetic effects on streptozotocin-nicotinamide-induced diabetic model and myotube cell of male mouse publication-title: Oxid Med Cell Longev doi: 10.1155/2018/7496936 – volume: 13 start-page: 10617 year: 2023 ident: CR49 article-title: Therapeutic effect of melatonin-loaded chitosan/lecithin nanoparticles on hyperglycemia and pancreatic beta cells regeneration in streptozotocin-induced diabetic rats publication-title: Sci Rep doi: 10.1038/s41598-023-36929-0 – volume: 4 start-page: 100367 year: 2022 ident: CR61 article-title: A crucial role of selenium nanoparticles for future perspectives publication-title: Results Chem doi: 10.1016/j.rechem.2022.100367 – volume: 23 start-page: 63 year: 2022 ident: CR58 article-title: nanoparticles potentiate insulin release and modulate antioxidant gene expression in pancreas of diabetic rats publication-title: Egypt J Med Hum Genet doi: 10.1186/s43042-022-00282-0 – volume: 40 start-page: 371 year: 2022 end-page: 372 ident: CR40 article-title: An Introduction to Tirzepatide publication-title: Clin Diabetes doi: 10.2337/cd22-0038 – volume: 60 start-page: 1586 year: 2017 end-page: 1593 ident: CR13 article-title: Metformin: clinical use in type 2 diabetes publication-title: Diabetologia doi: 10.1007/s00125-017-4336-x – volume: 13 start-page: 5096 year: 2020 end-page: 5106 ident: CR67 article-title: Green synthesis of gold nanoparticles from and its anti-diabetic activity on streptozotocin induced rats publication-title: Arab J Chem doi: 10.1016/j.arabjc.2020.02.009 – volume: 610 start-page: 121208 year: 2021 ident: CR107 article-title: Nanophytosomes for enhancement of rutin efficacy in oral administration for diabetes treatment in streptozotocin-induced diabetic rats publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2021.121208 – ident: CR101 – volume: 106 start-page: 220 year: 2017 end-page: 230 ident: CR52 article-title: Evaluation of anti-diabetic activity of glycyrrhizin-loaded nanoparticles in nicotinamide-streptozotocin-induced diabetic rats publication-title: Eur J Pharm Sci doi: 10.1016/j.ejps.2017.05.068 – volume: 25 start-page: 1224 issue: 1 year: 2018 end-page: 1233 ident: CR48 article-title: Liver-targeted delivery of insulin-loaded nanoparticles via enterohepatic circulation of bile acids publication-title: Drug Delivery doi: 10.1080/10717544.2018.1469685 – volume: 396 start-page: 2019 year: 2020 end-page: 2082 ident: CR3 article-title: The lancet commission on diabetes: using data to transform diabetes care and patient lives publication-title: Lancet doi: 10.1016/S0140-6736(20)32374-6 – volume: 20 start-page: 254 year: 2016 end-page: 267 ident: CR19 article-title: Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes: Past, present, and future publication-title: Indian J Endocrinol Metab doi: 10.4103/2230-8210.176351 – volume: 120 start-page: 2418 year: 2018 end-page: 2430 ident: CR94 article-title: In-vivo anti-diabetic and wound healing potential of chitosan/alginate/maltodextrin/pluronic-based mixed polymeric micelles: Curcumin therapeutic potential publication-title: Int J Biol Macromol doi: 10.1016/j.ijbiomac.2018.09.010 – volume: 376 start-page: 70 year: 2013 end-page: 80 ident: CR111 article-title: Oleanolic acid improves hepatic insulin resistance via antioxidant, hypolipidemic and anti-inflammatory effects publication-title: Mol Cell Endocrinol doi: 10.1016/j.mce.2013.06.014 – volume: 42 start-page: 1325 year: 2016 end-page: 1333 ident: CR115 article-title: Preparation, optimization, characterization and in vivo pharmacokinetic study of asiatic acid tromethamine salt-loaded solid lipid nanoparticles publication-title: Drug Dev Ind Pharm doi: 10.3109/03639045.2015.1135934 – volume: 21 start-page: 6275 year: 2020 ident: CR5 article-title: Pathophysiology of type 2 diabetes mellitus publication-title: Int J Mol Sci doi: 10.3390/ijms21176275 – volume: 10 start-page: 16315 year: 2018 end-page: 16326 ident: CR50 article-title: Encapsulation of curcumin nanoparticles with MMP9-responsive and thermos-sensitive hydrogel improves diabetic wound healing publication-title: ACS Appl Mater Interfaces doi: 10.1021/acsami.8b03868 – volume: 174 start-page: 2074 year: 2017 end-page: 2084 ident: CR89 article-title: Nano-curcumin safely prevents streptozotocin-induced inflammation and apoptosis in pancreatic beta cells for effective management of Type 1 diabetes mellitus publication-title: Br J Pharmacol doi: 10.1111/bph.13816 – volume: 133 start-page: 110941 year: 2021 ident: CR53 article-title: Long-term treatment of polysaccharides-based hydrogel microparticles as oral insulin delivery in streptozotocin-induced type 2 diabetic mice publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2020.110941 – volume: 10 start-page: 2436 year: 2022 ident: CR2 article-title: Current advances in the management of diabetes mellitus publication-title: Biomedicines doi: 10.3390/biomedicines10102436 – volume: 81 start-page: 104264 year: 2023 ident: CR116 article-title: Polymeric nanoformulation prototype based on a natural extract for the potential treatment of type 2 diabetes mellitus publication-title: J Drug Deliv Sci Technol doi: 10.1016/j.jddst.2023.104264 – volume: 9 start-page: 892 year: 2018 ident: CR114 article-title: Pharmacological properties, molecular mechanisms, and pharmaceutical development of asiatic acid: a pentacyclic triterpenoid of therapeutic promise publication-title: Front Pharmacol doi: 10.3389/fphar.2018.00892 – volume: 197 start-page: 111541 year: 2019 ident: CR63 article-title: Synthesis of ZnO nanoparticles using insulin-rich leaf extract: Anti-diabetic, antibiofilm and anti-oxidant properties publication-title: J Photochem Photobiol B doi: 10.1016/j.jphotobiol.2019.111541 – volume: 31 start-page: 2110 year: 2020 end-page: 2118 ident: CR64 article-title: Synergistic antidiabetic activity of ZnO nanoparticles encompassed by extract publication-title: Adv Powder Technol doi: 10.1016/j.apt.2020.03.004 – volume: 6 start-page: 456 year: 2015 end-page: 480 ident: CR24 article-title: Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus publication-title: World J Diabetes doi: 10.4239/wjd.v6.i3.456 – volume: 60 start-page: 3155 year: 2020 end-page: 3171 ident: CR85 article-title: The pharmacokinetics of flavanones publication-title: Crit Rev Food Sci Nutr doi: 10.1080/10408398.2019.1679085 – volume: 43 start-page: 1617 year: 2020 end-page: 1635 ident: CR4 article-title: Precision medicine in diabetes: a consensus report from the American diabetes association (ADA) and the European Association for the Study of Diabetes (EASD) publication-title: Diabetes Care doi: 10.2337/dci20-0022 – volume: 35 start-page: 1719 year: 2021 end-page: 1738 ident: CR106 article-title: Therapeutic benefits of rutin and its nanoformulations publication-title: Phytother Res doi: 10.1002/ptr.6904 – volume: 170 start-page: 124 year: 2017 end-page: 132 ident: CR82 article-title: Alginate coated chitosan core-shell nanoparticles for efficient oral delivery of naringenin in diabetic animals—an in vitro and in vivo approach publication-title: Carbohydr Polym doi: 10.1016/j.carbpol.2017.04.066 – volume: 32 start-page: 537 year: 2012 end-page: 541 ident: CR30 article-title: Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus publication-title: Nutr Res doi: 10.1016/j.nutres.2012.06.003 – volume: 11 start-page: 840 issue: 4 year: 2015 end-page: 848 ident: CR17 article-title: State of the art paper Sulfonylureas and their use in clinical practice publication-title: Arch Med Sci doi: 10.5114/aoms.2015.53304 – volume: 9 start-page: 227 year: 2019 end-page: 239 ident: CR55 article-title: pH-responsive calcium alginate hydrogel laden with protamine nanoparticles and hyaluronan oligosaccharide promotes diabetic wound healing by enhancing angiogenesis and antibacterial activity publication-title: Drug Deliv Transl Res doi: 10.1007/s13346-018-00609-8 – volume: 69 start-page: 143 year: 2017 end-page: 150 ident: CR51 article-title: Metformin-loaded alginate nanoparticles as an effective antidiabetic agent for controlled drug release publication-title: J Pharm Pharmacol doi: 10.1111/jphp.12672 – volume: 97 start-page: 1521 year: 2018 end-page: 1537 ident: CR37 article-title: Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2017.11.026 – volume: 37 start-page: 152 year: 2020 ident: CR104 article-title: Metabolic activity of anthocyanin extracts loaded into non-ionic niosomes in diet-induced obese mice publication-title: Pharm Res doi: 10.1007/s11095-020-02883-z – volume: 67 start-page: 220 year: 2017 end-page: 235 ident: CR105 article-title: Rutin: A review on extraction, identification and purification methods, biological activities and approaches to enhance its bioavailability publication-title: Trends Food Sci Technol doi: 10.1016/j.tifs.2017.07.008 – volume: 34 start-page: 102197 year: 2022 ident: CR71 article-title: Synthesis of gold nanoparticles (AuNPs) with improved anti-diabetic, antioxidant and anti-microbial activity from publication-title: J King Saud Univ Sci doi: 10.1016/j.jksus.2022.102197 – volume: 2018 start-page: 87 year: 2018 end-page: 100 ident: CR108 article-title: : chemistry and pharmacological activity publication-title: Sweeteners doi: 10.1007/978-3-319-27027-2_21 – volume: 2 start-page: 270 year: 2009 end-page: 278 ident: CR73 article-title: Plant polyphenols as dietary antioxidants in human health and disease publication-title: Oxid Med Cell Longev doi: 10.4161/oxim.2.5.9498 – volume: 18 start-page: 586 issue: 3 year: 2017 end-page: 594 ident: CR83 article-title: Enhanced solubility and bioavailability of naringenin via liposomal nanoformulation: preparation and in vitro and in vivo evaluations publication-title: AAPS PharmSciTech doi: 10.1208/s12249-016-0537-8 – volume: 14 start-page: 353 year: 2018 end-page: 364 ident: CR102 article-title: Preparation and characterization of hydroxyapatite nanoparticles carrying insulin and gallic acid for insulin oral delivery publication-title: Nanomedicine doi: 10.1016/j.nano.2017.11.012 – volume: 13 start-page: 574 year: 2023 ident: CR39 article-title: Nanoparticles: taking a unique position in medicine publication-title: Nanomaterials doi: 10.3390/nano13030574 – volume: 296 start-page: 190 year: 2019 end-page: 201 ident: CR86 article-title: Recent advances in topical delivery of flavonoids: A review publication-title: J Control Release doi: 10.1016/j.jconrel.2019.01.029 – volume: 30 start-page: 283 year: 2016 end-page: 291 ident: CR34 article-title: The hypoglycemic and synergistic effect of loganin, morroniside, and ursolic acid isolated from the fruits of publication-title: Phytother Res doi: 10.1002/ptr.5529 – volume: 12 start-page: 908 year: 2019 end-page: 931 ident: CR38 article-title: Nanoparticles: properties, applications and toxicities publication-title: Arab J Chem doi: 10.1016/j.arabjc.2017.05.011 – volume: 8 start-page: 174 issue: 3 year: 2018 ident: CR70 article-title: Synthesis of Gold Nanoparticles Using Leaf Extract of and their Antimicrobial Activity publication-title: Nanomaterials doi: 10.3390/nano8030174 – volume: 96 start-page: 610 year: 2020 end-page: 618 ident: CR12 article-title: Advances in the management of diabetes: therapies for type 2 diabetes publication-title: Postgrad Med J doi: 10.1136/postgradmedj-2019-137404 – volume: 212 start-page: 133 year: 2020 end-page: 139 ident: CR9 article-title: Advances in type 2 diabetes therapy: a focus on cardiovascular and renal outcomes publication-title: Med J Aust doi: 10.5694/mja2.50472 – volume: 97 start-page: 397 year: 2019 end-page: 405 ident: CR66 article-title: A comprehensive study on antidiabetic and antibacterial activities of ZnO nanoparticles biosynthesized using L seed extract publication-title: Mater Sci Eng C Mater Biol Appl doi: 10.1016/j.msec.2018.12.058 – volume: 16 start-page: 62 year: 2021 end-page: 76 ident: CR14 article-title: Trends of nanotechnology in type 2 diabetes mellitus treatment publication-title: Asian J Pharm Sci doi: 10.1016/j.ajps.2020.05.001 – volume: 89 start-page: 209 year: 2019 end-page: 238 ident: CR72 article-title: Effects of phytochemicals against diabetes publication-title: Adv Food Nutr Res doi: 10.1016/bs.afnr.2019.02.006 – volume: 199 start-page: 110782 year: 2019 ident: CR100 article-title: Formation of gallic acid layer on γ-AlOOH nanoparticles surface and their antioxidant and membrane-protective activity publication-title: J Inorg Biochem doi: 10.1016/j.jinorgbio.2019.110782 – volume: 154 start-page: 1496 year: 2020 end-page: 1504 ident: CR97 article-title: Novel polydatin-loaded chitosan nanoparticles for safe and efficient type 2 diabetes therapy: In silico, in vitro and in vivo approaches publication-title: Int J Biol Macromol doi: 10.1016/j.ijbiomac.2019.11.031 – volume: 33 start-page: 101983 year: 2021 ident: CR76 article-title: Synthesis of an environmentally quercetin nanoemulsion to ameliorate diabetic-induced cardiotoxicity publication-title: Biocatal Agric Biotechnol doi: 10.1016/j.bcab.2021.101983 – volume: 84 start-page: 112 year: 2016 end-page: 120 ident: CR99 article-title: Chitosan-based nanoparticles for rosmarinic acid ocular delivery—In vitro tests publication-title: Int J Biol Macromol doi: 10.1016/j.ijbiomac.2015.11.070 – volume: 57 start-page: 241 year: 2010 end-page: 246 ident: CR23 article-title: Modulatory effects of leaf gel extract on oxidative stress in rats treated with streptozotocin publication-title: J Pharm Pharmacol doi: 10.1211/0022357055416 – volume: 12 start-page: 11 year: 2019 ident: CR80 article-title: The therapeutic potential of naringenin: a review of clinical trials publication-title: Pharmaceuticals doi: 10.3390/ph12010011 – volume: 111 start-page: 498 year: 2018 end-page: 504 ident: CR43 article-title: Development of native and modified banana starch nanoparticles as vehicles for curcumin publication-title: Int J Biol Macromol doi: 10.1016/j.ijbiomac.2018.01.063 – volume: 62 start-page: 1791 year: 2013 end-page: 1799 ident: CR113 article-title: Biochemical basis of the antidiabetic activity of oleanolic acid and related pentacyclic triterpenes publication-title: Diabetes doi: 10.2337/db12-1215 – volume: 76 start-page: 1117 year: 2020 end-page: 1145 ident: CR11 article-title: 2020 expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2020.05.037 – volume: 11 start-page: 95 year: 2016 end-page: 104 ident: CR110 article-title: Significance of HbA1c test in diagnosis and prognosis of diabetic patients publication-title: Biomark Insights doi: 10.4137/BMI.S38440 – volume: 21 start-page: 505 year: 2020 end-page: 514 ident: CR60 article-title: Biosynthesis of selenium nanoparticles and their protective, antioxidative effects in streptozotocin induced diabetic rats publication-title: Sci Technol Adv Mater doi: 10.1080/14686996.2020.1788907 – volume: 125 start-page: 278 year: 2019 end-page: 289 ident: CR46 article-title: Combined synergetic potential of metformin loaded pectin-chitosan biohybrids nanoparticle for NIDDM publication-title: Int J Biol Macromol doi: 10.1016/j.ijbiomac.2018.12.009 – volume: 805 start-page: 012035 year: 2020 ident: CR69 article-title: Antidiabetic properties of phytosynthesized gold nanoparticles (AuNPs) from seed publication-title: IOP Conf Ser Mater Sci Eng doi: 10.1088/1757-899X/805/1/012035 – volume: 13 start-page: 226 year: 2018 end-page: 235 ident: CR93 article-title: Chitosan encapsulated nanocurcumin induces GLUT-4 translocation and exhibits enhanced anti-hyperglycemic function publication-title: Life Sci doi: 10.1016/j.lfs.2018.10.027 – volume: 206 start-page: 567 year: 2022 end-page: 579 ident: CR75 article-title: Role of polyphenols in combating type 2 diabetes and insulin resistance publication-title: Int J Biol Macromol doi: 10.1016/j.ijbiomac.2022.03.004 – volume: 2 start-page: 112 year: 2012 end-page: 123 ident: CR79 article-title: Development of quercetin nanoformulation and in vivo evaluation using streptozotocin induced diabetic rat model publication-title: Drug Deliv Transl Res doi: 10.1007/s13346-012-0063-5 – volume: 37 start-page: 14 year: 2014 end-page: 16 ident: CR21 article-title: Experimental and Clinical Pharmacology: Sodium-glucose co-transporter inhibitors: Mechanisms of action publication-title: Aust Prescr. doi: 10.18773/austprescr.2014.005 – volume: 32 start-page: 174 year: 2022 end-page: 187 ident: CR31 article-title: and streptozotocin-induced diabetes mellitus publication-title: Rev Bras Farmacogn doi: 10.1007/s43450-022-00231-3 – volume: 530 start-page: 430 year: 2017 end-page: 439 ident: CR44 article-title: Calcium alginate microspheres containing metformin hydrochloride niosomes and chitosomes aimed for oral therapy of type 2 diabetes mellitus publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2017.07.083 – volume: 559 start-page: 23 year: 2019 end-page: 36 ident: CR54 article-title: Silver nanoparticle impregnated chitosan-PEG hydrogel enhances wound healing in diabetes induced rabbits publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2019.01.019 – volume: 15 start-page: 605 issue: 7 year: 2012 end-page: 610 ident: CR32 article-title: Olive leaf extract as a hypoglycemic agent in both human diabetic subjects and in rats publication-title: J Med Food doi: 10.1089/jmf.2011.0243 – volume: 6 start-page: 226 year: 2014 end-page: 240 ident: CR36 article-title: Diabetes and Antidiabetic Herbal Formulations: An Alternative to Allopathy publication-title: Eur J Med. doi: 10.13187/ejm.2014.6.226 – volume: 23 start-page: 10988 year: 2022 ident: CR109 article-title: Glycyrrhizic acid and its derivatives: promising candidates for the management of type 2 diabetes mellitus and its complications publication-title: Int J Mol Sci doi: 10.3390/ijms231910988 – volume: 390 start-page: 124630 year: 2020 ident: CR112 article-title: Natural plant-derived polygalacturonic acid-oleanolic acid assemblies as oral-delivered nanomedicine for insulin resistance treatment publication-title: Chem Eng J doi: 10.1016/j.cej.2020.124630 – volume: 12 start-page: 7799 year: 2017 end-page: 7813 ident: CR78 article-title: Quercetin nanoparticle complex attenuated diabetic nephropathy via regulating the expression level of ICAM-1 on endothelium publication-title: Int J Nanomedicine doi: 10.2147/IJN.S146978 – volume: 14 start-page: 3217 year: 2022 ident: CR41 article-title: Natural polysaccharide-based nanodrug delivery systems for treatment of diabetes publication-title: Polymers (Basel) doi: 10.3390/polym14153217 – volume: 35 start-page: 2121 issue: 11 year: 2012 end-page: 2127 ident: CR27 article-title: Curcumin extract for prevention of type 2 diabetes publication-title: Diabetes Care doi: 10.2337/dc12-0116 – volume: 18 start-page: 3856 issue: 6 year: 2018 end-page: 3864 ident: CR96 article-title: Nanoliposomal resveratrol as a novel approach to treatment of diabetes mellitus publication-title: J Nanosci Nanotechnol doi: 10.1166/jnn.2018.15247 – volume: 134 start-page: 109818 year: 2020 ident: CR84 article-title: Formulation, physico-chemical characterization and antidiabetic potential of naringenin-loaded poly D, L lactide-co-glycolide (N-PLGA) nanoparticles publication-title: Eur Polym J doi: 10.1016/j.eurpolymj.2020.109818 – volume: 6 start-page: 94 issue: 3 year: 2019 ident: CR33 article-title: Functional foods and bioactive compounds: a review of its possible role on weight management and obesity’s metabolic consequences publication-title: Medicines doi: 10.3390/medicines6030094 – volume: 12 start-page: 204201882098022 year: 2021 ident: CR16 article-title: Should metformin remain the first-line therapy for treatment of type 2 diabetes? publication-title: Ther Adv Endocrinol Metab doi: 10.1177/2042018820980225 – volume: 13 start-page: 291 year: 2021 ident: CR81 article-title: Naringenin nano-delivery systems and their therapeutic applications publication-title: Pharmaceutics doi: 10.3390/pharmaceutics13020291 – volume: 284 start-page: 102251 year: 2020 ident: CR42 article-title: Drug nanodelivery systems based on natural polysaccharides against different diseases publication-title: Adv Colloid Interface Sci doi: 10.1016/j.cis.2020.102251 – volume: 36 start-page: S127 year: 2013 end-page: S138 ident: CR7 article-title: Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes publication-title: Diabetes Care doi: 10.2337/dcS13-2011 – volume: 384 start-page: 1248 year: 2021 end-page: 1260 ident: CR15 article-title: Glucose-lowering drugs to reduce cardiovascular risk in type 2 diabetes publication-title: N Engl J Med doi: 10.1056/NEJMcp2000280 – volume: 6 start-page: 332 year: 2016 end-page: 336 ident: CR25 article-title: Cinnamon extract lowers glucose, insulin and cholesterol in people with elevated serum glucose publication-title: J Tradit Complement Med doi: 10.1016/j.jtcme.2015.03.005 – volume: 4 start-page: 100509 year: 2022 ident: CR65 article-title: Green synthesis of ZnO nanoparticles using : Antioxidant, antibacterial and antidiabetic studies publication-title: Results Chem doi: 10.1016/j.rechem.2022.100509 – volume: 70 start-page: 1360 year: 2016 end-page: 1367 ident: CR103 article-title: Associations of dietary intakes of anthocyanins and berry fruits with risk of type 2 diabetes mellitus: a systematic review and meta-analysis of prospective cohort studies publication-title: Eur J Clin Nutr doi: 10.1038/ejcn.2016.142 – volume: 24 start-page: 1294 year: 2017 end-page: 1305 ident: CR57 article-title: Enhancing antidiabetic and antimicrobial performance of , and (L.) using silver nanoparticles publication-title: Saudi J Biol Sci. doi: 10.1016/j.sjbs.2015.06.026 – volume: 6 start-page: 943 year: 2017 end-page: 957 ident: CR8 article-title: Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis publication-title: Mol Metab doi: 10.1016/j.molmet.2017.06.019 – volume: 134 start-page: 270 year: 2019 end-page: 289 ident: CR56 article-title: Progress in the discovery of naturally occurring anti-diabetic drugs and in the identification of their molecular targets publication-title: Fitoterapia doi: 10.1016/j.fitote.2019.02.033 – volume: 615 start-page: 150 year: 2009 end-page: 154 ident: CR98 article-title: Rosmarinic acid suppresses retinal neovascularization via cell cycle arrest with increase of p21WAF1 expression publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2009.05.015 – volume: 11 start-page: 1085 year: 2022 ident: CR95 article-title: Resveratrol in treating diabetes and its cardiovascular complications: a review of its mechanisms of action publication-title: Antioxidants doi: 10.3390/antiox11061085 – volume: 6 start-page: 4592 year: 2021 end-page: 4606 ident: CR92 article-title: An intrinsically bioactive hydrogel with on-demand drug release behaviors for diabetic wound healing publication-title: Bioact Mater doi: 10.1016/j.bioactmat.2021.04.040 – volume: 16 start-page: 2150149 year: 2021 ident: CR47 article-title: Quality by design approach to formulate empagliflozin-loaded chitosan nanoparticles: in vitro, in vivo and pharmacokinetic evaluation of anti-diabetic drugs publication-title: Nano doi: 10.1142/S1793292021501496 – volume: 27 start-page: 67 year: 2004 end-page: 70 ident: CR18 article-title: Experimental and clinical pharmacology: Thiazolidinediones - mechanisms of action publication-title: Aust Prescr doi: 10.18773/austprescr.2004.059 – volume: 40 start-page: 163 year: 2007 end-page: 173 ident: CR35 article-title: Indian herbs and herbal drugs used for the treatment of diabetes publication-title: J Clin Biochem Nutr doi: 10.3164/jcbn.40.163 – volume: 213 start-page: 226 year: 2018 end-page: 235 ident: CR90 article-title: Chitosan encapsulated nanocurcumin induces GLUT-4 translocation and exhibits enhanced anti-hyperglycemic function publication-title: Life Sci doi: 10.1016/j.lfs.2018.10.027 – volume: 7 start-page: 332 year: 2017 end-page: 338 ident: CR28 article-title: Evaluation the effect of 50 and 100 mg doses of essential oil on glycemic indices, insulin resistance and serum inflammatory factors on patients with diabetes type II: A double-blind randomized placebo-controlled clinical trial publication-title: J Tradit Complement Med doi: 10.1016/j.jtcme.2016.08.004 – volume: 12 start-page: 2993 year: 2022 end-page: 2999 ident: CR68 article-title: Biosynthesis of gold nanoparticles using leaf extract of and in vivo assessment of its anti-diabetic efficacy publication-title: Drug Deliv Transl Res doi: 10.1007/s13346-022-01163-0 – volume: 12 start-page: 669448 year: 2021 ident: CR26 article-title: The effects of curcumin on diabetes mellitus: a systematic review publication-title: Front Endocrinol (Lausanne) doi: 10.3389/fendo.2021.669448 – volume: 23 start-page: 479 year: 2009 end-page: 486 ident: CR20 article-title: Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4) publication-title: Best Pract Res Clin Endocrinol Metab doi: 10.1016/j.beem.2009.03.004 – volume: 30 start-page: 1214 year: 2013 end-page: 1218 ident: CR29 article-title: Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses but suppresses postprandial glucagon in obese subjects publication-title: Diabetic Med doi: 10.1111/dme.12231 – volume: 35 start-page: 1636 year: 2011 end-page: 1644 ident: CR88 article-title: Myricitrin, a nitric oxide and protein kinase C inhibitor, exerts antipsychotic-like effects in animal models publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2011.06.002 – volume: 177 start-page: 389 year: 2019 end-page: 398 ident: CR91 article-title: Curcumin-loaded PLA-PEG copolymer nanoparticles for treatment of liver inflammation in streptozotocin-induced diabetic rats publication-title: Colloids Surf B Biointerfaces doi: 10.1016/j.colsurfb.2019.02.024 – volume: 137 start-page: 155332 year: 2022 ident: CR10 article-title: Pharmacotherapy of type 2 diabetes: an update and future directions publication-title: Metabolism doi: 10.1016/j.metabol.2022.155332 – volume: 8 start-page: 361 year: 2018 end-page: 376 ident: CR22 article-title: An update on natural compounds in the remedy of diabetes mellitus: a systematic review publication-title: J Tradit Complement Med doi: 10.1016/j.jtcme.2017.08.012 – volume: 14 start-page: 3217 year: 2022 ident: 1376_CR41 publication-title: Polymers (Basel) doi: 10.3390/polym14153217 – volume: 13 start-page: 291 year: 2021 ident: 1376_CR81 publication-title: Pharmaceutics doi: 10.3390/pharmaceutics13020291 – volume: 16 start-page: 62 year: 2021 ident: 1376_CR14 publication-title: Asian J Pharm Sci doi: 10.1016/j.ajps.2020.05.001 – volume: 40 start-page: 163 year: 2007 ident: 1376_CR35 publication-title: J Clin Biochem Nutr doi: 10.3164/jcbn.40.163 – volume: 13 start-page: 574 year: 2023 ident: 1376_CR39 publication-title: Nanomaterials doi: 10.3390/nano13030574 – volume: 62 start-page: 1791 year: 2013 ident: 1376_CR113 publication-title: Diabetes doi: 10.2337/db12-1215 – volume: 30 start-page: 1214 year: 2013 ident: 1376_CR29 publication-title: Diabetic Med doi: 10.1111/dme.12231 – volume: 106 start-page: 220 year: 2017 ident: 1376_CR52 publication-title: Eur J Pharm Sci doi: 10.1016/j.ejps.2017.05.068 – volume: 11 start-page: 893 year: 2022 ident: 1376_CR62 publication-title: Plants doi: 10.3390/plants11070893 – volume: 7 start-page: 332 year: 2017 ident: 1376_CR28 publication-title: J Tradit Complement Med doi: 10.1016/j.jtcme.2016.08.004 – volume: 23 start-page: 10988 year: 2022 ident: 1376_CR109 publication-title: Int J Mol Sci doi: 10.3390/ijms231910988 – volume: 30 start-page: 283 year: 2016 ident: 1376_CR34 publication-title: Phytother Res doi: 10.1002/ptr.5529 – volume: 197 start-page: 111541 year: 2019 ident: 1376_CR63 publication-title: J Photochem Photobiol B doi: 10.1016/j.jphotobiol.2019.111541 – volume: 11 start-page: 1085 year: 2022 ident: 1376_CR95 publication-title: Antioxidants doi: 10.3390/antiox11061085 – volume: 42 start-page: 1325 year: 2016 ident: 1376_CR115 publication-title: Drug Dev Ind Pharm doi: 10.3109/03639045.2015.1135934 – volume: 37 start-page: 14 year: 2014 ident: 1376_CR21 publication-title: Aust Prescr. doi: 10.18773/austprescr.2014.005 – volume: 12 start-page: 669448 year: 2021 ident: 1376_CR26 publication-title: Front Endocrinol (Lausanne) doi: 10.3389/fendo.2021.669448 – volume: 2018 start-page: 1 year: 2018 ident: 1376_CR87 publication-title: Oxid Med Cell Longev doi: 10.1155/2018/7496936 – volume: 79 start-page: 727 year: 2004 ident: 1376_CR74 publication-title: Am J Clin Nutr doi: 10.1093/ajcn/79.5.727 – volume: 16 start-page: 2150149 year: 2021 ident: 1376_CR47 publication-title: Nano doi: 10.1142/S1793292021501496 – volume: 2018 start-page: 87 year: 2018 ident: 1376_CR108 publication-title: Sweeteners doi: 10.1007/978-3-319-27027-2_21 – volume: 76 start-page: 1117 year: 2020 ident: 1376_CR11 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2020.05.037 – volume: 70 start-page: 1360 year: 2016 ident: 1376_CR103 publication-title: Eur J Clin Nutr doi: 10.1038/ejcn.2016.142 – volume: 12 start-page: 7799 year: 2017 ident: 1376_CR78 publication-title: Int J Nanomedicine doi: 10.2147/IJN.S146978 – volume: 2 start-page: 112 year: 2012 ident: 1376_CR79 publication-title: Drug Deliv Transl Res doi: 10.1007/s13346-012-0063-5 – volume: 13 start-page: 5096 year: 2020 ident: 1376_CR67 publication-title: Arab J Chem doi: 10.1016/j.arabjc.2020.02.009 – volume: 4 start-page: 100509 year: 2022 ident: 1376_CR65 publication-title: Results Chem doi: 10.1016/j.rechem.2022.100509 – volume: 12 start-page: 908 year: 2019 ident: 1376_CR38 publication-title: Arab J Chem doi: 10.1016/j.arabjc.2017.05.011 – volume: 9 start-page: 227 year: 2019 ident: 1376_CR55 publication-title: Drug Deliv Transl Res doi: 10.1007/s13346-018-00609-8 – volume: 31 start-page: 2110 year: 2020 ident: 1376_CR64 publication-title: Adv Powder Technol doi: 10.1016/j.apt.2020.03.004 – volume: 32 start-page: 174 year: 2022 ident: 1376_CR31 publication-title: Rev Bras Farmacogn doi: 10.1007/s43450-022-00231-3 – volume: 805 start-page: 012035 year: 2020 ident: 1376_CR69 publication-title: IOP Conf Ser Mater Sci Eng doi: 10.1088/1757-899X/805/1/012035 – volume: 18 start-page: 586 issue: 3 year: 2017 ident: 1376_CR83 publication-title: AAPS PharmSciTech doi: 10.1208/s12249-016-0537-8 – volume: 20 start-page: 254 year: 2016 ident: 1376_CR19 publication-title: Indian J Endocrinol Metab doi: 10.4103/2230-8210.176351 – volume: 15 start-page: 605 issue: 7 year: 2012 ident: 1376_CR32 publication-title: J Med Food doi: 10.1089/jmf.2011.0243 – volume: 384 start-page: 1248 year: 2021 ident: 1376_CR15 publication-title: N Engl J Med doi: 10.1056/NEJMcp2000280 – volume: 6 start-page: 226 year: 2014 ident: 1376_CR36 publication-title: Eur J Med. doi: 10.13187/ejm.2014.6.226 – volume: 206 start-page: 567 year: 2022 ident: 1376_CR75 publication-title: Int J Biol Macromol doi: 10.1016/j.ijbiomac.2022.03.004 – volume: 60 start-page: 1586 year: 2017 ident: 1376_CR13 publication-title: Diabetologia doi: 10.1007/s00125-017-4336-x – volume: 330 start-page: 618 year: 2021 ident: 1376_CR1 publication-title: J Control Release doi: 10.1016/j.jconrel.2021.01.002 – volume: 6 start-page: 40162 year: 2016 ident: 1376_CR59 publication-title: RSC Adv doi: 10.1039/C5RA24391B – volume: 12 start-page: 732 year: 2023 ident: 1376_CR77 publication-title: Antioxidants doi: 10.3390/antiox12030732 – volume: 154 start-page: 1496 year: 2020 ident: 1376_CR97 publication-title: Int J Biol Macromol doi: 10.1016/j.ijbiomac.2019.11.031 – volume: 4 start-page: 100367 year: 2022 ident: 1376_CR61 publication-title: Results Chem doi: 10.1016/j.rechem.2022.100367 – volume: 12 start-page: 204201882098022 year: 2021 ident: 1376_CR16 publication-title: Ther Adv Endocrinol Metab doi: 10.1177/2042018820980225 – volume: 134 start-page: 109818 year: 2020 ident: 1376_CR84 publication-title: Eur Polym J doi: 10.1016/j.eurpolymj.2020.109818 – volume: 2 start-page: 270 year: 2009 ident: 1376_CR73 publication-title: Oxid Med Cell Longev doi: 10.4161/oxim.2.5.9498 – volume: 6 start-page: 456 year: 2015 ident: 1376_CR24 publication-title: World J Diabetes doi: 10.4239/wjd.v6.i3.456 – volume: 137 start-page: 155332 year: 2022 ident: 1376_CR10 publication-title: Metabolism doi: 10.1016/j.metabol.2022.155332 – volume: 25 start-page: 1224 issue: 1 year: 2018 ident: 1376_CR48 publication-title: Drug Delivery doi: 10.1080/10717544.2018.1469685 – volume: 14 start-page: 353 year: 2018 ident: 1376_CR102 publication-title: Nanomedicine doi: 10.1016/j.nano.2017.11.012 – volume: 60 start-page: 3155 year: 2020 ident: 1376_CR85 publication-title: Crit Rev Food Sci Nutr doi: 10.1080/10408398.2019.1679085 – volume: 57 start-page: 241 year: 2010 ident: 1376_CR23 publication-title: J Pharm Pharmacol doi: 10.1211/0022357055416 – volume: 170 start-page: 124 year: 2017 ident: 1376_CR82 publication-title: Carbohydr Polym doi: 10.1016/j.carbpol.2017.04.066 – volume: 21 start-page: 6275 year: 2020 ident: 1376_CR5 publication-title: Int J Mol Sci doi: 10.3390/ijms21176275 – volume: 12 start-page: 2993 year: 2022 ident: 1376_CR68 publication-title: Drug Deliv Transl Res doi: 10.1007/s13346-022-01163-0 – volume: 18 start-page: 3856 issue: 6 year: 2018 ident: 1376_CR96 publication-title: J Nanosci Nanotechnol doi: 10.1166/jnn.2018.15247 – volume: 34 start-page: 102197 year: 2022 ident: 1376_CR71 publication-title: J King Saud Univ Sci doi: 10.1016/j.jksus.2022.102197 – volume: 615 start-page: 150 year: 2009 ident: 1376_CR98 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2009.05.015 – volume: 36 start-page: S127 year: 2013 ident: 1376_CR7 publication-title: Diabetes Care doi: 10.2337/dcS13-2011 – volume: 27 start-page: 67 year: 2004 ident: 1376_CR18 publication-title: Aust Prescr doi: 10.18773/austprescr.2004.059 – volume: 35 start-page: 1636 year: 2011 ident: 1376_CR88 publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2011.06.002 – volume: 11 start-page: 840 issue: 4 year: 2015 ident: 1376_CR17 publication-title: Arch Med Sci doi: 10.5114/aoms.2015.53304 – volume: 559 start-page: 23 year: 2019 ident: 1376_CR54 publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2019.01.019 – volume: 6 start-page: 943 year: 2017 ident: 1376_CR8 publication-title: Mol Metab doi: 10.1016/j.molmet.2017.06.019 – volume: 67 start-page: 220 year: 2017 ident: 1376_CR105 publication-title: Trends Food Sci Technol doi: 10.1016/j.tifs.2017.07.008 – volume: 13 start-page: 776 year: 2021 ident: 1376_CR45 publication-title: Nanoscale doi: 10.1039/D0NR06104B – volume: 32 start-page: 537 year: 2012 ident: 1376_CR30 publication-title: Nutr Res doi: 10.1016/j.nutres.2012.06.003 – volume: 212 start-page: 133 year: 2020 ident: 1376_CR9 publication-title: Med J Aust doi: 10.5694/mja2.50472 – volume: 6 start-page: 4592 year: 2021 ident: 1376_CR92 publication-title: Bioact Mater doi: 10.1016/j.bioactmat.2021.04.040 – volume: 213 start-page: 226 year: 2018 ident: 1376_CR90 publication-title: Life Sci doi: 10.1016/j.lfs.2018.10.027 – volume: 12 start-page: 11 year: 2019 ident: 1376_CR80 publication-title: Pharmaceuticals doi: 10.3390/ph12010011 – volume: 120 start-page: 2418 year: 2018 ident: 1376_CR94 publication-title: Int J Biol Macromol doi: 10.1016/j.ijbiomac.2018.09.010 – volume: 23 start-page: 479 year: 2009 ident: 1376_CR20 publication-title: Best Pract Res Clin Endocrinol Metab doi: 10.1016/j.beem.2009.03.004 – volume: 376 start-page: 70 year: 2013 ident: 1376_CR111 publication-title: Mol Cell Endocrinol doi: 10.1016/j.mce.2013.06.014 – volume: 6 start-page: 94 issue: 3 year: 2019 ident: 1376_CR33 publication-title: Medicines doi: 10.3390/medicines6030094 – volume: 530 start-page: 430 year: 2017 ident: 1376_CR44 publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2017.07.083 – ident: 1376_CR101 doi: 10.1088/1757-899X/172/1/012042 – volume: 390 start-page: 124630 year: 2020 ident: 1376_CR112 publication-title: Chem Eng J doi: 10.1016/j.cej.2020.124630 – volume: 69 start-page: 143 year: 2017 ident: 1376_CR51 publication-title: J Pharm Pharmacol doi: 10.1111/jphp.12672 – volume: 40 start-page: 371 year: 2022 ident: 1376_CR40 publication-title: Clin Diabetes doi: 10.2337/cd22-0038 – volume: 11 start-page: 95 year: 2016 ident: 1376_CR110 publication-title: Biomark Insights doi: 10.4137/BMI.S38440 – volume: 21 start-page: 505 year: 2020 ident: 1376_CR60 publication-title: Sci Technol Adv Mater doi: 10.1080/14686996.2020.1788907 – volume: 174 start-page: 2074 year: 2017 ident: 1376_CR89 publication-title: Br J Pharmacol doi: 10.1111/bph.13816 – volume: 610 start-page: 121208 year: 2021 ident: 1376_CR107 publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2021.121208 – volume: 296 start-page: 190 year: 2019 ident: 1376_CR86 publication-title: J Control Release doi: 10.1016/j.jconrel.2019.01.029 – volume: 84 start-page: 112 year: 2016 ident: 1376_CR99 publication-title: Int J Biol Macromol doi: 10.1016/j.ijbiomac.2015.11.070 – volume: 97 start-page: 1521 year: 2018 ident: 1376_CR37 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2017.11.026 – volume: 111 start-page: 498 year: 2018 ident: 1376_CR43 publication-title: Int J Biol Macromol doi: 10.1016/j.ijbiomac.2018.01.063 – volume: 8 start-page: 361 year: 2018 ident: 1376_CR22 publication-title: J Tradit Complement Med doi: 10.1016/j.jtcme.2017.08.012 – volume: 6 start-page: 332 year: 2016 ident: 1376_CR25 publication-title: J Tradit Complement Med doi: 10.1016/j.jtcme.2015.03.005 – volume: 13 start-page: 226 year: 2018 ident: 1376_CR93 publication-title: Life Sci doi: 10.1016/j.lfs.2018.10.027 – volume: 35 start-page: 1719 year: 2021 ident: 1376_CR106 publication-title: Phytother Res doi: 10.1002/ptr.6904 – volume: 33 start-page: 101983 year: 2021 ident: 1376_CR76 publication-title: Biocatal Agric Biotechnol doi: 10.1016/j.bcab.2021.101983 – volume: 133 start-page: 110941 year: 2021 ident: 1376_CR53 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2020.110941 – volume: 10 start-page: 2436 year: 2022 ident: 1376_CR2 publication-title: Biomedicines doi: 10.3390/biomedicines10102436 – volume: 284 start-page: 102251 year: 2020 ident: 1376_CR42 publication-title: Adv Colloid Interface Sci doi: 10.1016/j.cis.2020.102251 – volume: 37 start-page: 152 year: 2020 ident: 1376_CR104 publication-title: Pharm Res doi: 10.1007/s11095-020-02883-z – volume: 23 start-page: 63 year: 2022 ident: 1376_CR58 publication-title: Egypt J Med Hum Genet doi: 10.1186/s43042-022-00282-0 – volume: 8 start-page: 174 issue: 3 year: 2018 ident: 1376_CR70 publication-title: Nanomaterials doi: 10.3390/nano8030174 – volume: 177 start-page: 389 year: 2019 ident: 1376_CR91 publication-title: Colloids Surf B Biointerfaces doi: 10.1016/j.colsurfb.2019.02.024 – volume: 396 start-page: 2019 year: 2020 ident: 1376_CR3 publication-title: Lancet doi: 10.1016/S0140-6736(20)32374-6 – volume: 89 start-page: 209 year: 2019 ident: 1376_CR72 publication-title: Adv Food Nutr Res doi: 10.1016/bs.afnr.2019.02.006 – volume: 24 start-page: 1294 year: 2017 ident: 1376_CR57 publication-title: Saudi J Biol Sci. doi: 10.1016/j.sjbs.2015.06.026 – volume: 13 start-page: 10617 year: 2023 ident: 1376_CR49 publication-title: Sci Rep doi: 10.1038/s41598-023-36929-0 – volume: 43 start-page: 1617 year: 2020 ident: 1376_CR4 publication-title: Diabetes Care doi: 10.2337/dci20-0022 – volume: 10 start-page: 16315 year: 2018 ident: 1376_CR50 publication-title: ACS Appl Mater Interfaces doi: 10.1021/acsami.8b03868 – volume: 134 start-page: 270 year: 2019 ident: 1376_CR56 publication-title: Fitoterapia doi: 10.1016/j.fitote.2019.02.033 – volume: 35 start-page: 2121 issue: 11 year: 2012 ident: 1376_CR27 publication-title: Diabetes Care doi: 10.2337/dc12-0116 – volume: 125 start-page: 278 year: 2019 ident: 1376_CR46 publication-title: Int J Biol Macromol doi: 10.1016/j.ijbiomac.2018.12.009 – volume: 81 start-page: 104264 year: 2023 ident: 1376_CR116 publication-title: J Drug Deliv Sci Technol doi: 10.1016/j.jddst.2023.104264 – volume: 96 start-page: 610 year: 2020 ident: 1376_CR12 publication-title: Postgrad Med J doi: 10.1136/postgradmedj-2019-137404 – volume: 97 start-page: 397 year: 2019 ident: 1376_CR66 publication-title: Mater Sci Eng C Mater Biol Appl doi: 10.1016/j.msec.2018.12.058 – volume: 63 start-page: 2158 year: 2014 ident: 1376_CR6 publication-title: Diabetes doi: 10.2337/db13-0949 – volume: 9 start-page: 892 year: 2018 ident: 1376_CR114 publication-title: Front Pharmacol doi: 10.3389/fphar.2018.00892 – volume: 199 start-page: 110782 year: 2019 ident: 1376_CR100 publication-title: J Inorg Biochem doi: 10.1016/j.jinorgbio.2019.110782 |
| SSID | ssj0000778816 |
| Score | 2.3524873 |
| SecondaryResourceType | review_article |
| Snippet | Objectives
Diabetes mellitus (DM) is a long-standing and non-transmissible endocrine disease that generates significant clinical issues and currently affects... Diabetes mellitus (DM) is a long-standing and non-transmissible endocrine disease that generates significant clinical issues and currently affects... Objectives Diabetes mellitus (DM) is a long-standing and non-transmissible endocrine disease that generates significant clinical issues and currently affects... ObjectivesDiabetes mellitus (DM) is a long-standing and non-transmissible endocrine disease that generates significant clinical issues and currently affects... |
| SourceID | pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 267 |
| SubjectTerms | Biological products Development and progression Diabetes Diabetes therapy Drug delivery systems Drugs Endocrinology Health aspects Hypoglycemic agents Isoflavones Medicine Medicine & Public Health Metabolic Diseases Nanotechnology Natural resources Review Review Article Vehicles |
| Title | Multiple nanotechnological approaches using natural compounds for diabetes management |
| URI | https://link.springer.com/article/10.1007/s40200-023-01376-1 https://www.ncbi.nlm.nih.gov/pubmed/38932892 https://www.proquest.com/docview/3163826436 https://www.proquest.com/docview/3072815026 https://pubmed.ncbi.nlm.nih.gov/PMC11196251 |
| Volume | 23 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dS9xAEB_Eg-KL1O-09rqC4ING8r3ZhyKneEjhfPLAt2Wz2bSC5qx3QvvfO7PZRHPYQp8Ct5PkMjuT-U3mC-BQKJVXvEz9IiuFn2iufaVjChdSQFFVaPOpGnlynV1Nk--36e0KtOOOHAPn77p2NE9q-nR_-vvXnzNU-G9dGRz5QAFenjKDUGF89IYGNl5EqXwO7ts3M6fm6XbeHJp1H41v6Opo3r9Mz1Ytv7HfmKzldMqlmKo1VeOPsO4wJhs1QrEBK6behA8TF0XfgunEZRGyWtWzRftxnbaLtT3GzZxRSvwPZjt_4gLlntMIpjlDmMvaT7bsoUuf2Ybp-PLm4sp34xV8nfJ44Vel4YWoEp1FAVdJoNE7NEmIx4onVZ6XBk05ul86EJEuAqOymAvED5XgqTCxjndgtZ7VZg8Yz7SqOP5M_QYzFahSFAo9wwJBcV6EqQdhy0ipXe9xGoFxL7uuyZb5EpkvLfNl6MFxd85j03njn9RfaX9kUz3aqa0c4ZajdU7S2IMjS0GihPfWytUf4BNQC6we5X6PEhVO95dbGZCtvMqYcC2Cyzjz4KBbpjMpia02s2ekCXiUIwCPkGa3EZnuyQg3ou8beZD3hKkjoDbg_ZX67qdtB47WSqAXiyw4aeXu9X_9nWOf_ou_n2EtQjjXJMntw-ri6dl8QTi2KIYwGI3Pz6-HVtdeACcgLJY |
| linkProvider | Scholars Portal |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Multiple+nanotechnological+approaches+using+natural+compounds+for+diabetes+management&rft.jtitle=Journal+of+diabetes+and+metabolic+disorders&rft.au=Stoleru%2C+Ozana+Andreea&rft.au=Burlec%2C+Ana+Flavia&rft.au=Mircea%2C+Cornelia&rft.au=Felea%2C+Maura+Gabriela&rft.date=2024-06-01&rft.issn=2251-6581&rft.eissn=2251-6581&rft.volume=23&rft.issue=1&rft.spage=267&rft.epage=287&rft_id=info:doi/10.1007%2Fs40200-023-01376-1&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s40200_023_01376_1 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2251-6581&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2251-6581&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2251-6581&client=summon |